US Stock MarketDetailed Quotes

Bright Minds Biosciences (DRUG)

Watchlist
  • 89.160
  • +0.480+0.54%
Close Apr 24 16:00 ET
  • 89.160
  • 0.0000.00%
Post 20:01 ET
872.62MMarket Cap-44.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bright Minds Biosciences (DRUG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-289.18%-5.82M
-369.77%-8.69M
-538.77%-2.96M
-855.07%-1.81M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Net income from continuing operations
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Operating gains losses
188.00%1.43M
-2,987.96%-312.69K
-1,696.30%-1.16M
24,837.69%2.46M
443.28%11.76K
-3,953.47%-1.63M
-122.33%-10.13K
-139.44%-64.46K
107.57%9.88K
-59.39%2.17K
Depreciation and amortization
-8.10%19.79K
4.79%76.87K
-74.62%17.01K
153.02%15.85K
24.12%22.48K
18.88%21.53K
1.25%73.36K
270.03%67.02K
-265.00%-29.89K
-0.01%18.11K
Other non cash items
1.87%6.58K
300.79%35.85K
41,412.52%1.7M
-694,961.16%-1.68M
538.76%13.58K
117.33%6.46K
-54.71%8.95K
8.03%4.09K
-105.29%-242
-60.14%2.13K
Change In working capital
-740.39%-996.37K
1,294.00%554.99K
1,176.05%1.19M
-147.33%-379.48K
71.12%-138.63K
-120.45%-118.56K
104.23%39.81K
136.57%93.39K
52.35%-153.43K
-200.16%-479.99K
-Change in receivables
-81.96%-30.56K
-2,639.92%-362.85K
-325.72%-140.44K
-107.29%-39.07K
67.23%-166.55K
-108.43%-16.8K
-111.15%-13.24K
-149.46%-32.99K
862.32%536.01K
-2,061.29%-508.21K
-Change in prepaid assets
-42.89%-59.05K
-308.22%-771.28K
-76.56%-279.52K
-613.91%-307K
-955.94%-143.44K
-843.64%-41.32K
-238.17%-188.94K
-238.82%-158.31K
-215.89%-43K
181.02%16.76K
-Change in payables and accrued expense
-1,400.22%-906.76K
598.01%1.69M
466.10%1.61M
94.83%-33.41K
1,395.54%171.36K
-110.20%-60.44K
120.21%241.99K
165.28%284.69K
-123.84%-646.44K
-97.58%11.46K
Cash from discontinued investing activities
Operating cash flow
-289.18%-5.82M
-369.77%-8.69M
-173.77%-1.27M
-1,559.00%-3.5M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-74.27%13.39M
10,456.43%85.57M
141,535.98%33.32M
23.17%-16.87K
1,126.47%225.38K
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
Net issuance payments of debt
-9.39%-26.03K
-11.61%-100.15K
-9.43%-26.11K
-16.68%-25.62K
-12.17%-24.63K
-8.35%-23.79K
-4.20%-89.73K
-10.23%-23.86K
-2.18%-21.96K
-2.17%-21.96K
Net common stock issuance
-71.33%13.94M
9,021.95%82.1M
--33.47M
--0
--0
5,303.22%48.63M
-26.08%900K
--0
--0
--0
Proceeds from stock option exercised by employees
-99.75%8.75K
1,301,295.70%3.93M
50,231.46%152K
--8.75K
--250.01K
--3.52M
-99.97%302
--302
--0
--0
Net other financing activities
-540.37%-536.12K
---360.14K
---276.42K
--0
--0
---83.72K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-74.27%13.39M
10,456.43%85.57M
141,535.98%33.32M
23.17%-16.87K
1,126.47%225.38K
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
Net cash flow
Beginning cash position
1,349.43%82.91M
-15.23%5.72M
730.14%51.39M
838.57%55.68M
756.25%57.9M
-15.23%5.72M
-41.97%6.75M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
Current changes in cash
-85.01%7.57M
7,494.66%76.88M
6,684.81%32.05M
-1,713.55%-3.52M
-165.99%-2.2M
90,232.60%50.55M
78.50%-1.04M
60.08%-486.73K
113.05%218.2K
46.09%-827.05K
Effect of exchange rate changes
-188.07%-1.44M
2,567.45%312.63K
-3,291.77%-529.04K
-2,048.12%-771.55K
-678.29%-16.85K
3,954.03%1.63M
125.84%11.72K
110.14%16.58K
-69.64%39.61K
59.39%-2.17K
End cash Position
53.80%89.05M
1,349.43%82.91M
1,349.43%82.91M
730.14%51.39M
838.57%55.68M
756.25%57.9M
-15.23%5.72M
-15.23%5.72M
-23.86%6.19M
-38.66%5.93M
Free cash flow
-289.18%-5.82M
-369.77%-8.69M
-173.77%-1.27M
-1,559.00%-3.5M
-201.24%-2.43M
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -289.18%-5.82M-369.77%-8.69M-538.77%-2.96M-855.07%-1.81M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Net income from continuing operations -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Operating gains losses 188.00%1.43M-2,987.96%-312.69K-1,696.30%-1.16M24,837.69%2.46M443.28%11.76K-3,953.47%-1.63M-122.33%-10.13K-139.44%-64.46K107.57%9.88K-59.39%2.17K
Depreciation and amortization -8.10%19.79K4.79%76.87K-74.62%17.01K153.02%15.85K24.12%22.48K18.88%21.53K1.25%73.36K270.03%67.02K-265.00%-29.89K-0.01%18.11K
Other non cash items 1.87%6.58K300.79%35.85K41,412.52%1.7M-694,961.16%-1.68M538.76%13.58K117.33%6.46K-54.71%8.95K8.03%4.09K-105.29%-242-60.14%2.13K
Change In working capital -740.39%-996.37K1,294.00%554.99K1,176.05%1.19M-147.33%-379.48K71.12%-138.63K-120.45%-118.56K104.23%39.81K136.57%93.39K52.35%-153.43K-200.16%-479.99K
-Change in receivables -81.96%-30.56K-2,639.92%-362.85K-325.72%-140.44K-107.29%-39.07K67.23%-166.55K-108.43%-16.8K-111.15%-13.24K-149.46%-32.99K862.32%536.01K-2,061.29%-508.21K
-Change in prepaid assets -42.89%-59.05K-308.22%-771.28K-76.56%-279.52K-613.91%-307K-955.94%-143.44K-843.64%-41.32K-238.17%-188.94K-238.82%-158.31K-215.89%-43K181.02%16.76K
-Change in payables and accrued expense -1,400.22%-906.76K598.01%1.69M466.10%1.61M94.83%-33.41K1,395.54%171.36K-110.20%-60.44K120.21%241.99K165.28%284.69K-123.84%-646.44K-97.58%11.46K
Cash from discontinued investing activities
Operating cash flow -289.18%-5.82M-369.77%-8.69M-173.77%-1.27M-1,559.00%-3.5M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -74.27%13.39M10,456.43%85.57M141,535.98%33.32M23.17%-16.87K1,126.47%225.38K5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K
Net issuance payments of debt -9.39%-26.03K-11.61%-100.15K-9.43%-26.11K-16.68%-25.62K-12.17%-24.63K-8.35%-23.79K-4.20%-89.73K-10.23%-23.86K-2.18%-21.96K-2.17%-21.96K
Net common stock issuance -71.33%13.94M9,021.95%82.1M--33.47M--0--05,303.22%48.63M-26.08%900K--0--0--0
Proceeds from stock option exercised by employees -99.75%8.75K1,301,295.70%3.93M50,231.46%152K--8.75K--250.01K--3.52M-99.97%302--302--0--0
Net other financing activities -540.37%-536.12K---360.14K---276.42K--0--0---83.72K----------------
Cash from discontinued financing activities
Financing cash flow -74.27%13.39M10,456.43%85.57M141,535.98%33.32M23.17%-16.87K1,126.47%225.38K5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K
Net cash flow
Beginning cash position 1,349.43%82.91M-15.23%5.72M730.14%51.39M838.57%55.68M756.25%57.9M-15.23%5.72M-41.97%6.75M-23.86%6.19M-38.66%5.93M-39.69%6.76M
Current changes in cash -85.01%7.57M7,494.66%76.88M6,684.81%32.05M-1,713.55%-3.52M-165.99%-2.2M90,232.60%50.55M78.50%-1.04M60.08%-486.73K113.05%218.2K46.09%-827.05K
Effect of exchange rate changes -188.07%-1.44M2,567.45%312.63K-3,291.77%-529.04K-2,048.12%-771.55K-678.29%-16.85K3,954.03%1.63M125.84%11.72K110.14%16.58K-69.64%39.61K59.39%-2.17K
End cash Position 53.80%89.05M1,349.43%82.91M1,349.43%82.91M730.14%51.39M838.57%55.68M756.25%57.9M-15.23%5.72M-15.23%5.72M-23.86%6.19M-38.66%5.93M
Free cash flow -289.18%-5.82M-369.77%-8.69M-173.77%-1.27M-1,559.00%-3.5M-201.24%-2.43M-81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -